MUC16 and female reproductive organ cancer: The Gynecologic Cancer Intergroup (GCIG) adopted a chemotherapy response criterion based on the decrease in the percentage of CA-125, and a 50% decrease in the CA-125 level that could be sustained for at least 28 days was determined as treatment response [11].